Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus.
The infectivity of flavivirus particles depends on a maturation process that is triggered by the proteolytic cleavage of the precursor of the M protein (prM). This activation cleavage is naturally performed by ubiquitous cellular proteases of the furin family, which typically recognize the multibasic sequence motif R-X-R/K-R. Previously, we demonstrated that a tick-borne encephalitis virus (TBEV) mutant with an altered cleavage motif, R-X-R, produced immature, noninfectious particles that could be activated by exogenous trypsin, which cleaves after single basic residues. Here, we report the adaptation of this mutant to chymotrypsin, a protease specific for large, hydrophobic amino acid residues. Using selection pressure in cell culture, two different mutations conferring a chymotrypsin-dependent phenotype were identified. Surprisingly, one of these mutations (Ser85Phe) occurred three positions upstream of the natural cleavage site. The other mutation (Arg89His) arose at the natural cleavage position but involved a His residue, which is not a typical chymotrypsin cleavage site. Efficient cleavage of protein prM and activation by the heterologous protease were confirmed using various recombinant TBEV mutants. Mutants with only the originally selected mutations exhibited unimpaired export kinetics and were genotypically stable during at least six cell culture passages. However, in contrast to the wild-type virus or trypsin-dependent mutants, chymotrypsin-dependent mutants were not neurovirulent in suckling mice. Our results demonstrate that flaviviruses with altered protease specificities can be generated and suggest that this approach can be used for the construction of viral mutants or vectors that can be activated on demand and have restricted tissue tropism and virulence.
Fischl
Wolfgang
W
Clinical Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria.
Elshuber
Sigrid
S
Schrauf
Sabrina
S
Mandl
Christian W
CW
D000818:Animals; D002460:Cell Line; D002918:Chymotrypsin / Q000378:metabolism*; D006224:Cricetinae; D004669:Encephalitis Viruses, Tick-Borne / Q000737:chemistry / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D004926:Escherichia coli / Q000235:genetics; D005240:Feasibility Studies; D007700:Kinetics; D009154:Mutation; D010957:Plasmids; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics / Q000302:isolation & purification; D011995:Recombination, Genetic; D012641:Selection, Genetic; D012680:Sensitivity and Specificity; D020539:Sequence Analysis, Protein; D014162:Transfection; D014357:Trypsin / Q000378:metabolism; D014759:Viral Envelope Proteins / Q000032:analysis / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D014774:Virulence / Q000235:genetics / Q000502:physiology
D012367:RNA, Viral; D014759:Viral Envelope Proteins; C074932:prM protein, Flavivirus; C065696:glycoprotein E, Flavivirus; D002918:Chymotrypsin; D014357:Trypsin